Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Ladenburg Thalmann Downgrades NextCure to Neutral

Ladenburg Thalmann Downgrades NextCure to Neutral

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.

byBenzinga Newsdesk

November 4, 2022

1 minute read

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.

News

Protesters Storm Brazil’s Government Buildings; President Da Silva Calls Them ‘Fanatic Fascists’

By Michael Cohen

January 8, 7:33 PM

Brazil's Congress, presidential palace and Supreme Court were overrun on Sunday by supporters of the country’s former President Jair Bolsonaro.

EWZ

Analyst Ratings

What 4 Analyst Ratings Have To Say About Clarus

By Benzinga Insights

May 3, 2:02 PM

Within the last quarter, Clarus (NASDAQ:CLAR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

CLAR

Visa Inks Pact With Financial Messaging Services Provider Swift To Boost Global Cross-Border B2B Payments

By Nabaparna Bhattacharya

September 19, 11:01 AM

Visa Inc.(NYSE: V) collaborated with Belgium-based secure financial messaging services provider Swift to streamline international business-to-business (B2B) payments and

Getty Images Stock Drops In After-Hours Trading After Disappointing Q2 Results

By Ryan Gustafson

August 14, 4:47 PM

Getty Images Holdings, Inc. (NYSE: GETY) shares are trading lower in the after-hours session Monday after the company reported second-quarter earnings.

GETY

Ladenburg Thalmann Downgrades NextCure to Neutral

Related Posts

Protesters Storm Brazil’s Government Buildings; President Da Silva Calls Them ‘Fanatic Fascists’

What 4 Analyst Ratings Have To Say About Clarus

Visa Inks Pact With Financial Messaging Services Provider Swift To Boost Global Cross-Border B2B Payments

Getty Images Stock Drops In After-Hours Trading After Disappointing Q2 Results